Abstract
The main limiting factor for liver resection is insufficient future liver remnant (FLR). Portal vein embolization (PVE) is a standard of care treatment to induce FLR hypertrophy, but it is not always efficient. Radioembolization (RE) has a potential to induce liver hypertrophy for PVE-refractory patients. However, this was reported only for the patients with hepatocellular carcinoma. We described two cases of lobar RE after PVE failure for the patients with colorectal liver metastases. This enabled to reach sufficient FLR, provide good local disease control and bridge the patients to extended hepatectomy.
Similar content being viewed by others
References
Abulkhir A, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49–57. https://doi.org/10.1097/SLA.0b013e31815f6e5b.
Pamecha V, et al. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol. 2009;16:1202–7. https://doi.org/10.1245/s10434-008-0269-4.
Fernandez-Ros N, et al. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB Offic J Int Hepato Pancreato Biliary Assoc. 2014;16:243–9. https://doi.org/10.1111/hpb.12095.
Vouche M, et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013;59:1029–36. https://doi.org/10.1016/j.jhep.2013.06.015.
Theysohn JM, et al. Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma. Clin Radiol. 2014;69:172–8. https://doi.org/10.1016/j.crad.2013.09.009.
Teo JY, et al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. HPB Offic J Int Hepato Pancreato Biliary Assoc. 2016;18:7–12. https://doi.org/10.1016/j.hpb.2015.07.002.
Bouazza F, et al. Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World J Gastroenterol. 2015;21:9666–700. https://doi.org/10.3748/wjg.v21.i32.9666.
Madoff DC, et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiogr Rev Publ Radiol Soc N Am. 2002;22:1063–76. https://doi.org/10.1148/radiographics.22.5.g02se161063.
May BJ, Madoff DC. Portal vein embolization: rationale, technique, and current application. Semin Interv Radiol. 2012;29:81–9. https://doi.org/10.1055/s-0032-1312568.
Kang BK, et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma after attempted portal vein embolization in 25 patients. AJR Am J Roentgenol. 2009;193:W446–451. https://doi.org/10.2214/ajr.09.2479.
Wallace MJ, Ahrar K, Madoff DC. Chemoembolization of the liver after portal vein embolization: report of three cases. J Vasc Interv Radiol JVIR. 2008;19:1513–7. https://doi.org/10.1016/j.jvir.2008.07.010.
Radunz S, et al. Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma. Clin Transplant. 2017. https://doi.org/10.1111/ctr.13096.
Pardo F, et al. The post-SIR-spheres surgery study (P4S): retrospective analysis of safety following hepatic resection or transplantation in patients previously treated with selective internal radiation therapy with Yttrium-90 resin microspheres. Ann Surg Oncol. 2017;24:2465–73. https://doi.org/10.1245/s10434-017-5950-z.
Martin AN, et al. Clinical factors and postoperative impact of bile leak after liver resection. J Gastrointest Surg Offic J Soc Surg Alimentary Tract. 2018;22:661–7. https://doi.org/10.1007/s11605-017-3650-4.
Henry LR, et al. Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up. Ann Surg Oncol. 2015;22:467–74. https://doi.org/10.1245/s10434-014-4012-z.
Livraghi T, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–51. https://doi.org/10.1148/radiol.2262012198.
Livraghi T, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer. 2003;97:3027–35. https://doi.org/10.1002/cncr.11426.
Lambert LA, Colacchio TA, Barth RJ Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg. 2000;135:473–9. https://doi.org/10.1001/archsurg.135.4.473.
Kito Y, Nagino M, Nimura Y. Doppler sonography of hepatic arterial blood flow velocity after percutaneous transhepatic portal vein embolization. Am J Roentgenol. 2001;176:909–12. https://doi.org/10.2214/ajr.176.4.1760909.
Kennedy A, et al. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus. J Gastrointest Oncol. 2017;8:1079–99. https://doi.org/10.21037/jgo.2017.09.10.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical Approval and Informed Consent Statements
IRB approval was not required for this type of study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kurilova, I., Pompa, V., Guerrero, R. et al. 90Y-Radioembolization After Failed Portal Vein Embolization for Colorectal Liver Metastases: A Case Report. Cardiovasc Intervent Radiol 43, 1232–1236 (2020). https://doi.org/10.1007/s00270-020-02537-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-020-02537-y